Interactions between a left ventricular assist device and implantable cardioverter-defibrillator

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 9, 2012, Pages

  Netzler, Peter C ^a   Vasuki, Nagavardhan ^a   Peura, Jennifer L ^a   Gold, Michael R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ICD; LVAD

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CORONARY HEMODYNAMICS; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART TRANSPLANTATION; HUMAN; KIDNEY TUMOR; LEFT VENTRICULAR ASSIST DEVICE; NONISCHEMIC CARDIOMYOPATHY; PULMONARY HYPERTENSION; PULSE GENERATOR; SUDDEN DEATH; TELEMETRY;

ARTIFACTS; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; HEART-ASSIST DEVICES; HUMANS; MIDDLE AGED;

EID: 84866143718     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03370.x     Document Type: Article

References (12)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
2. The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
3. Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D, Daubert J, et al,. For the MADIT II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1-e62.
5. Jacob S, Cherian PK, Ghumman WS, Das MK,. "Pseudo" Faraday cage: A solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Interv Card Electrophysiol 2010; 28: 221-225.
6. Biviano A, Mancini D, Naka Y, Arellano J, Garan H,. Overcoming electromagnetic interference by LVADs on ICD function by shielding the ICD programmer wand and extension cable. Pacing Clin Electrophysiol 2009; 32: 959-962.
7. Baran DA, Martin T, Blicharz D, Carr C, Zucker MJ, McBride L, Camacho M,. Simple method to eliminate interference between LVADs and cardiac rhythm devices. Pacing Clin Electrophysiol 2009; 32: 1142-1145.
8. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S,. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007; 99: 1151-1153.
9. Cesario D, Saxon L, Cao M, Bowdish M, Cunningham M,. Ventricular tachycardia in the era of ventricular assist devices. J Cardiovasc Electrophysiol 2011; 22: 359-363.
10. Anderson M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F,. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 2009; 28: 733-735.
11. Mehta R, Doshi AA, Hasan AK, Love CJ, Pizzuto M, Sai-Sudhakar C, Chan DP. Device interactions with advanced cardiomyopathy. J Am Coll Cardiol 2008; 51: 1614-1615.
12. Matthews JC, Betley D, Morady F, Pelosi F,. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2007; 18: 1107-1108.